What DeepSeek’s model releases mean for the future of AI
We dig into the implications of China-based DeepSeek’s rapid ascent on the AI infrastructure landscape, the private sector, and enterprise AI strategies.
We dig into the implications of China-based DeepSeek’s rapid ascent on the AI infrastructure landscape, the private sector, and enterprise AI strategies.
Tech companies' growing power demands and component supply shortages have altered nuclear development timelines. We look at how fusion startups and small modular reactor (SMR) developers are adapting.
Critical infrastructure sectors are being exposed to costly cyberattacks. This brief explores how industrials firms have responded by investing in and partnering with OT security firms and how healthcare companies can follow suit.
We surveyed 50 senior strategy leaders to understand their genAI implementation tactics — and why some teams are seeing better results than others.
From AI’s ascendance to cautious dealmaking, we break down the trends reshaping digital health in 2024 using CB Insights data.
From a 7-year low in dealmaking to M&A gaining steam, we break down key changes in the fintech landscape using CB Insights data.
With industry leaders divided in their approaches, we look at the winners and losers in the open-source vs. closed-source landscape and what enterprises need to think about next for adoption.
In this webinar, our expert explores how leading enterprises are integrating genAI into their strategies to drive results and stay ahead of the competition.
We highlight notable generative AI deals, partnerships, and big tech activity in December 2024.
From AI’s banner year to an 8-year low in global dealmaking, we break down key changes in the venture landscape using CB Insights data.
AI promises to accelerate the path from bench to bedside. Using CB Insights data, we highlight emerging markets in the preclinical phase that are ripe for pharma investments and partnerships.
We map out 60+ companies developing AI agents & copilots for industrial applications, including manufacturing, logistics, semiconductors, defense, and construction.
How did venture fare in 2024, and what’s ahead for 2025? In this webinar, our expert breaks down the year’s funding landscape, why it matters, and the trends set to shape the future.
We analyze funding and acquisitions data, clinical progress, and partnership strategies to help pharma companies and investors navigate the maturing AI landscape in drug discovery.
Pharma giants and diagnostic testing leaders looking to expand in cancer detection should watch high-momentum liquid biopsy startups like Harbinger Health and Delfi Diagnostics.
Nearly 1 in 2 new unicorns is an AI company. We visualize every billion-dollar startup around the globe and break down emerging areas of opportunity.
From screening resumes to conducting assessments and handling questions, we map the new wave of companies automating employee hiring and break down what HR leaders need to know about the market.
We highlight notable generative AI deals, partnerships, and big tech activity in November 2024.
With the rise of EVs and AVs, fleet management solutions are expanding in scope to accommodate blended fleets. We break down what this means for fleet telematics & management companies, identifying who they should have on their radars to build out their capabilities.
The Digital Health 50 is CB Insights’ annual list of the most promising digital health startups in the world.
We mined Roche’s acquisitions, investments, and partnerships to discern the company's strategic priorities. Here’s what pharma and diagnostics companies need to pay attention to.
We examine what’s driving recent investment, partnership, and exit activity in the autonomous driving space to identify leaders and determine the market's direction.
Discover the key trends our experts anticipate will shape the tech landscape in 2025.
The future of LLMs. Caregiving humanoid robots. Crypto’s baby steps. We use CB Insights data to uncover 15 emerging trends that will shape the tech landscape for years to come.
From in-home humanoids to autonomous labs, we highlight the growing opportunities in robotics markets for providers and other healthcare stakeholders.